Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannu Norppa

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Mutation Research|December 4, 2003
Genetic susceptibility, biomarker respones, and cancerHannu Norppa
IARC Scientific Publications|April 2, 2004
Cytogenetic biomarkersHannu Norppa
Toxicology Letters|April 20, 2004
Cytogenetic biomarkers and genetic polymorphismsHannu Norppa
Toxicology|February 28, 2007
Correspondence to: "Emmert, B., Bünger, J., Keuch, K., Müller, M., Emmert, S., Hallier, E., Westphal, G.A., 2002. Mutagenicity of cytochrome P450 2E1 substrates in the Ames test with the metabolic competent S. typhimurium strain YG7108pin3ERb5. Toxicology 228, 66-76"Hannu Norppa
Nanotoxicology|September 30, 2010
Genotoxicity testing of nanomaterials--conclusionsHelmut Greim, Hannu Norppa
Bioengineering (Basel, Switzerland)|December 2, 2017
Safety Aspects of Bio-Based NanomaterialsJulia Catalán, Hannu Norppa
Mutagenesis|April 26, 2003
What do human micronuclei contain?Hannu Norppa, Ghita C-M Falck
Nanotoxicology|October 20, 2017
A theoretical approach for a weighted assessment of the mutagenic potential of nanomaterialsJulia Catalán, Helene Stockmann-Juvala, Hannu Norppa
Carcinogenesis|May 23, 2002
Influence of GSTM1 and GSTT1 genotypes on sister chromatid exchange induction by styrene in cultured human lymphocytesSabrina Bernardini, Ari Hirvonen, Hilkka Järventaus, et al.
Mutagenesis|March 7, 2002
Nature of anaphase laggards and micronuclei in female cytokinesis-blocked lymphocytesGhita C-M Falck, Julia Catalán, Hannu Norppa
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Mutation Research|December 4, 2003
Genetic susceptibility, biomarker respones, and cancerHannu Norppa
IARC Scientific Publications|April 2, 2004
Cytogenetic biomarkersHannu Norppa
Toxicology Letters|April 20, 2004
Cytogenetic biomarkers and genetic polymorphismsHannu Norppa
Toxicology|February 28, 2007
Correspondence to: "Emmert, B., Bünger, J., Keuch, K., Müller, M., Emmert, S., Hallier, E., Westphal, G.A., 2002. Mutagenicity of cytochrome P450 2E1 substrates in the Ames test with the metabolic competent S. typhimurium strain YG7108pin3ERb5. Toxicology 228, 66-76"Hannu Norppa
Nanotoxicology|September 30, 2010
Genotoxicity testing of nanomaterials--conclusionsHelmut Greim, Hannu Norppa
Bioengineering (Basel, Switzerland)|December 2, 2017
Safety Aspects of Bio-Based NanomaterialsJulia Catalán, Hannu Norppa
Mutagenesis|April 26, 2003
What do human micronuclei contain?Hannu Norppa, Ghita C-M Falck
Nanotoxicology|October 20, 2017
A theoretical approach for a weighted assessment of the mutagenic potential of nanomaterialsJulia Catalán, Helene Stockmann-Juvala, Hannu Norppa
Carcinogenesis|May 23, 2002
Influence of GSTM1 and GSTT1 genotypes on sister chromatid exchange induction by styrene in cultured human lymphocytesSabrina Bernardini, Ari Hirvonen, Hilkka Järventaus, et al.
Mutagenesis|March 7, 2002
Nature of anaphase laggards and micronuclei in female cytokinesis-blocked lymphocytesGhita C-M Falck, Julia Catalán, Hannu Norppa
Pageof 8